Neostigmine Methylsulfate
Approved
Approval ID
454d54dc-b803-4519-81e8-ac7d21e6aae1
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Apr 7, 2023
Manufacturers
FDA
Civica, Inc.
DUNS: 081373942
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Neostigmine Methylsulfate
PRODUCT DETAILS
NDC Product Code72572-462
Application NumberANDA207042
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateApril 7, 2023
Generic NameNeostigmine Methylsulfate
INGREDIENTS (6)
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
NEOSTIGMINE METHYLSULFATEActive
Quantity: 1 mg in 1 mL
Code: 98IMH7M386
Classification: ACTIB
PHENOLInactive
Quantity: 4.5 mg in 1 mL
Code: 339NCG44TV
Classification: IACT
SODIUM ACETATEInactive
Quantity: 0.2 mg in 1 mL
Code: 4550K0SC9B
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT